Robert W. Buckheit - Concepedia

Author

Robert W. Buckheit

Also Known As

Buckheit Junior, R.W., Christa E. Buckheit, R BUCKHEIT, R Buckheit, R W Buckheit, R. Buckheit, R. W. Buckheit, R. W. JUN. BUCKHEIT, R.W Buckheit, R.W. Buckheit

240

Publications

9.9K

Citations

H-Index

103

Concepts

All Affiliations

Southern Research Institute ImQuest BioSciences (United States)National Cancer Institute Purdue University West Lafayette Science Applications International Corporation (United States)

About

Robert W. Buckheit is an author at Southern Research Institute specializing in medicine, hiv, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	83	5.8K
2	Natural Sciences	25	38	2.1K
3	Engineering	10	10	342
4	Health Sciences	2	2	141
5	Social Sciences	2	2	48

Robert W. Buckheit

138

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development Michael R. Boyd, Kirk R. Gustafson, James B. McMahon, Antimicrobial Agents and Chemotherapy Viral ReplicationImmunologyEscherichia ColiAntiviral DrugSimian Immunodeficiency Virus	1997	607
HIV inhibitory natural products. Part 7. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum Yoel Kashman, Kirk R. Gustafson, Ray W. Fuller, Journal of Medicinal Chemistry	1992	546
Isolation and Characterization of Griffithsin, a Novel HIV-inactivating Protein, from the Red Alga Griffithsia sp. Toshiyuki Mori, Barry R. O’Keefe, Raymond C. Sowder, Journal of Biological Chemistry	2004	444
Synthesis and Biological Activity of Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 2-Aryl-Substituted Benzimidazoles Thomas Roth, Marshall Morningstar, Paul L. Boyer, Journal of Medicinal Chemistry Antiviral DrugHiv-1 Wt RtPharmaceutical ChemistryMedicinal ChemistryAntiviral Drug Development	1997	369
Circulins A and B. Novel human immunodeficiency virus (HIV)-inhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia. Kirk R. Gustafson, Raymond C. Sowder, Louis E. Henderson, Journal of the American Chemical Society GlycobiologyImmunologyAltmetric Attention ScorePeptide ScienceAntiviral Drug	1994	304
Combinatorially selected guanosine-quartet structureis a potent inhibitor of human immunodeficiency virus envelope-mediated cellfusion. Jacqueline R. Wyatt, Timothy A. Vickers, Joseph L. Roberson, Proceedings of the National Academy of Sciences Potent InhibitorTetramer FormationImmunologyMolecular BiologyGuanosine-quartet Structureis	1994	300
Anti-HIV Michellamines from Ancistrocladus korupensis Michael R. Boyd, Yali F. Hallock, John H. Cardellina, Journal of Medicinal Chemistry	1994	231
Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS William G. Rice, Jeffrey G. Supko, Louis Malspeis, Science Medicinal ChemistryZinc Finger-reactive CompoundsNeurovirologyMedicineHuman Retrovirus	1995	231
Shikonin, a Component of Chinese Herbal Medicine, Inhibits Chemokine Receptor Function and Suppresses Human Immunodeficiency Virus Type 1 Xin Chen, Lu Yang, Ning Zhang, Antimicrobial Agents and Chemotherapy PhytoalexinBiochemistryTraditional Chinese MedicineMedicineChinese Herbal Medicine	2003	227
A Potent Novel Anti-HIV Protein from the Cultured Cyanobacterium <i>Scytonema varium</i> Heidi R. Bokesch, Barry R. O’Keefe, Tawnya C. McKee, Biochemistry Intrachain Disulfide BondsUnique ProteinMedicineImmunologyAntiviral Response	2003	205

Page 1